New or old antidepressants? Benefits of new drugs are exaggerated.
作者信息
Owens D
机构信息
Division of Psychiatry and Behavioural Sciences, Leeds University.
出版信息
BMJ. 1994 Nov 12;309(6964):1281-2. doi: 10.1136/bmj.309.6964.1281.
Abstract
摘要
相似文献
1
New or old antidepressants? Benefits of new drugs are exaggerated.
BMJ. 1994 Nov 12;309(6964):1281-2. doi: 10.1136/bmj.309.6964.1281.
2
New or old antidepressants? New is better.
BMJ. 1994 Nov 12;309(6964):1280-1. doi: 10.1136/bmj.309.6964.1280.
3
Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United States.
J Occup Environ Med. 2010 Feb;52(2):115-24. doi: 10.1097/JOM.0b013e3181cb5b10.
4
Who bears the costs of antidepressants in Australia?
Med J Aust. 1995 Feb 6;162(3):162; author reply 164. doi: 10.5694/j.1326-5377.1995.tb138485.x.
5
Who bears the costs of antidepressants in Australia?
Med J Aust. 1995 Feb 6;162(3):162; author reply 164. doi: 10.5694/j.1326-5377.1995.tb138484.x.
6
Ranking antidepressants.
Lancet. 2009 May 23;373(9677):1760-1; author reply 1761-2. doi: 10.1016/S0140-6736(09)60976-4.
7
Pharmacoeconomic issues in the treatment of depression.
Pharmacotherapy. 1995 Nov-Dec;15(6 Pt 2):76S-83S.
8
Social functioning and the treatment of depression.
J Clin Psychiatry. 2000;61 Suppl 1:33-8.
9
Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
J Affect Disord. 2008 Nov;111(1):106-12. doi: 10.1016/j.jad.2008.02.002. Epub 2008 Mar 14.
10
Using pharmacoeconomic data to compare antidepressant therapies.
Manag Care. 2001 Aug;10(8 Suppl):14-5; discussion 18-22.
引用本文的文献
1
A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists.
Clin Drug Investig. 1998;16(1):53-61. doi: 10.2165/00044011-199816010-00007.
2
The need for an iterative process for assessing economic outcomes associated with SSRIs.
Pharmacoeconomics. 2000 Sep;18(3):205-14. doi: 10.2165/00019053-200018030-00001.
3
Mirtazapine. A pharmacoeconomic review of its use in depression.
Pharmacoeconomics. 2000 May;17(5):515-34. doi: 10.2165/00019053-200017050-00008.
4
Antidepressant drug choice for first users in two regions in The Netherlands.
Pharm World Sci. 1999 Jun;21(3):132-6. doi: 10.1023/a:1008675402004.
5
Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.
Pharmacoeconomics. 1996 May;9(5):430-42. doi: 10.2165/00019053-199609050-00006.
6
Paroxetine. A pharmacoeconomic evaluation of its use in depression.
Pharmacoeconomics. 1995 Jul;8(1):62-81. doi: 10.2165/00019053-199508010-00008.
7
Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
BMJ. 1995 Jun 3;310(6992):1433-8. doi: 10.1136/bmj.310.6992.1433.
本文引用的文献
1
Effective and acceptable treatment for depression.
BMJ. 1993 Apr 24;306(6885):1126. doi: 10.1136/bmj.306.6885.1126-b.
2
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
BMJ. 1993 Mar 13;306(6879):683-7. doi: 10.1136/bmj.306.6879.683.
3
The use of animals in research.
BMJ. 1992 Jul 4;305(6844):1. doi: 10.1136/bmj.305.6844.1.
4
Selective serotonin reuptake inhibitors.
BMJ. 1992 Jun 27;304(6843):1644-6. doi: 10.1136/bmj.304.6843.1644.
5
Suicide and fatal antidepressant poisoning.
Eur J Med. 1992 Oct;1(6):343-8.
Zotero 插件